Ann: Half Yearly Report and Accounts, page-23

First 23 Last

Share
Profile

Follow
banksy808

4,125 Posts.

362

01/03/19

11:37

Post #: 37618492
Share

Originally posted by Awoonga: ↑

banksy,

"gross profit as a % has slid from 52% to 36%" - to emphasise this is a trite misleading, wouldn't you agree?

Gross profit is also up 142% from the corresponding half year period last year.

Revenue has really only just started to accelerate. Comparing the last 6 months with the corresponding previous period is overall deceptive on both positive and negative fronts. The last quarter revenue was up 90% from the previous quarter and it's these two quarters that make up the 6 months of the half year. Effectively the first of the two quarters is dragging down the overall 6 month result.
Then we have the cost of the Zenvia purchase which clouds the numbers.

I for one, am more focused on the quarter on quarter results.

Seeing that the CR camp believe that a CR is coming based on the reported figures, they should also be able to forecast the size of the CR too.

How much? $1 million, $2 million or $x million before we are cash flow positive?

I'm not discounting a CR outright. But based on the last quarter on quarter results, I can't see it being all the large if there was one.

Expand

"Seeing that the CR camp believe that a CR is coming based on the reported figures, they should also be able to forecast the size of the CR too."

seeing that you asked for 2 and only got circa 1 million last cap raise

i'd say it will be small next time round

but who will invest?

SYT Price at posting: 0.9¢ Sentiment: Sell Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

AW1

American West does it again at Storm with visually identified thick copper hits at Cyclone, Lightning Ridge

GRE

Greentech finds lithium trend across 5.5 km at WA's Kobe South

LGM

Legacy shares jump on discovery of multiple epithermal veins at Bauloora JV

PYC

PYC commences new study on drug for eye condition Retinitis Pigmentosa type 11